Curable (XKRX:086460) Change In Receivables : ₩-3 Mil (TTM As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Curable Change In Receivables?

Curable's change in receivables for the quarter that ended in Dec. 2024 was ₩-3 Mil. It means Curable's Accounts Receivable increased by ₩3 Mil from Dec. 2023 to Dec. 2024 .

Curable's change in receivables for the fiscal year that ended in Dec. 2024 was ₩-3 Mil. It means Curable's Accounts Receivable increased by ₩3 Mil from Dec. 2023 to Dec. 2024 .

Curable's Accounts Receivable for the quarter that ended in Dec. 2024 was ₩20 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Curable's Days Sales Outstanding for the six months ended in Dec. 2024 was 2.45.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Curable's liquidation value for the six months ended in Dec. 2024 was ₩-11,812 Mil.

Curable Change In Receivables Historical Data

The historical data trend for Curable's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curable Change In Receivables Chart

Curable Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Change In Receivables

30.61

-26.84

14.95

-3.28

Curable Semi-Annual Data
	Dec21	Dec22	Dec23	Dec24
Change In Receivables	30.61	-26.84	14.95	-3.28

Curable Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-3 Mil.

Curable (XKRX:086460) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Curable's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	20.13	/	1501.249	*	91
=	2.45

2. In Ben Graham's calculation of liquidation value, Curable's accounts receivable are only considered to be worth 75% of book value:

Curable's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	147.088	-	12269.883	+	0.75 * 20.13	+	0.5 * 591.821
=	-11,812

Curable Change In Receivables Related Terms

Thank you for viewing the detailed overview of Curable's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Curable Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Curable Inc (XKRX:086460) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

93, Dongtan-daero 23-gil, 10th Floor, Gyeonggi-do, Hwaseong-si, KOR

Website

http://www.snp-genetics.com

Curable Inc provides genome analysis service.

Curable Headlines

No Headlines